WHALE.TIPS CONTENT

Thursday, December 30, 2021 15:47:31 UTC

BIONTECH SE: We entered a call option, $250.00 strike price, at 9:30 AM with a limit buy. We exited 1 hour later by limit sale for a 157% profit!

Taking profits, selling 1/3 position.(More)

@pfizerinc @pfizer

#bntx #biontechse #biotech #covid #vaccine

RELATED:

Tue, Dec 28, 21
NVAX: Novavax Inc

Thu, Dec 23, 21
NVAX: Novavax Inc

Tue, Dec 21, 21
NVAX: Novavax Inc

Wed, Dec 8, 21
PFE: Pfizer Inc

BNTX

BioNTech SE
Wed, Sep 28, 22 (EOD)
Price: $133.79
Volume 932158
RELATED:

Tue, Dec 28, 21
NVAX: Novavax Inc

Thu, Dec 23, 21
NVAX: Novavax Inc

Tue, Dec 21, 21
NVAX: Novavax Inc

Wed, Dec 8, 21
PFE: Pfizer Inc

BNTX

BioNTech SE
Wed, Sep 28, 22 (EOD)
Price: $133.79
Volume 932158

Tuesday, December 21, 2021 20:12:17 UTC

NOVAVAX INC: We entered a call option, $180.00 strike price, at 11:13 AM with a limit buy. We exited 3 hours later by limit sale for a 100% profit!

Cleared final positions after Joe Biden Spoke.(More)

NVAX: NOVAVAX INC

Tuesday, December 21, 2021 20:12:17 UTC

NOVAVAX INC: We entered a call option, $180.00 strike price, at 11:13 AM with a limit buy. We exited 3 hours later by limit sale for a 100% profit!

Cleared final positions after Joe Biden Spoke.

#nvax #bntx #pfe #mrna #novavaxinc #nvax #novavaxinc #covid #vaccine #pfizer #who #biontech


Monday, December 20, 2021 12:57:10 UTC

With an emergency approval for use by the WHO, Novavax is ripping in premarket, and options have been historically adjusting very well for this stock.

The stock increased after World Health Organization granted the vaccine company and the Serum Institute of India an emergency use authorization for their Covid-19 vaccine.

Covovax, which is manufactured and marketed by the Serum Institute for India and other developing nations, has been awarded emergency use status by the WHO.

Novavax's Covid-19 vaccine is protein-based, unlike the vaccines developed by the Pfizer (PFE) and BioNTech (BNTX) alliance and Moderna (MRNA), which are based on messenger RNA drug technology.

NOTE: This is not an endorsement or rejection of vaccines. This is a stock market news item.(More)

NOVAVAX APPROVED FOR EMERGENCY USE

Monday, December 20, 2021 12:57:10 UTC

With an emergency approval for use by the WHO, Novavax is ripping in premarket, and options have been historically adjusting very well for this stock.

The stock increased after World Health Organization granted the vaccine company and the Serum Institute of India an emergency use authorization for their Covid-19 vaccine.

Covovax, which is manufactured and marketed by the Serum Institute for India and other developing nations, has been awarded emergency use status by the WHO.

Novavax's Covid-19 vaccine is protein-based, unlike the vaccines developed by the Pfizer (PFE) and BioNTech (BNTX) alliance and Moderna (MRNA), which are based on messenger RNA drug technology.

NOTE: This is not an endorsement or rejection of vaccines. This is a stock market news item.

#nvax #novavaxinc #covid #vaccine #pfizer #who #biontech


PFIZER MAY HAVE OMICRON BEAT

12.8.21 1:03 PM UTC

Pfizer and BioNTech have announced a two-shot vaccine, plus a third booster was able to neutralize the new Omicron variant, and could be ready by March 2022.

#pfizer #biontech #omicron


PFIZER MAY HAVE OMICRON BEAT

Wednesday, December 08, 2021 13:03:58 UTC

Pfizer and BioNTech have announced a two-shot vaccine, plus a third booster was able to neutralize the new Omicron variant, and could be ready by March 2022.

#pfizer #biontech #omicron #covid #americanairlines #booster #vaccine


OMICRON CASES APPROACHING HALF OF USA

12.6.21 12:58 PM UTC

Cases of the latest Covid variant, omicron have been identified in a third of all U.S. states. The FDA looks to expedite authorization for modified vaccines.

#covid #pfizer #pfe


OMICRON CASES APPROACHING HALF OF USA

Monday, December 06, 2021 12:58:13 UTC

Cases of the latest Covid variant, omicron have been identified in a third of all U.S. states. The FDA looks to expedite authorization for modified vaccines.

#covid #pfizer #pfe #biontech #bntc #moderna #mrna #vaccine #omicron